Comparison of Three Tacrolimus-Based Immunosuppressive Regimens in Lung Transplantation

Sangeeta M. Bhorade*, Ashby Jordan, Jaime Villanueva, Andrew Yu, Holly Kramer, Wickii T. Vigneswaran, Edward R. Garrity

*Corresponding author for this work

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Immunosuppressive therapy for solid organ transplantation has significantly evolved over the past decade. While these therapies have been found to be beneficial in abdominal organ transplantation, the efficacy of these therapies remains unclear in lung transplantation. We retrospectively compared three potent immunosuppressive regimens in our lung transplant population: Group 1 (tacrolimus/azathioprine/prednisone), Group 2 (tacrolimus/azathioprine/prednisone/daclizumab) and Group 3 (tacrolimus/mycophenolate mofetil/prednisone/daclizumab). We compared these three groups with respect to 3-year rates of acute rejection, chronic rejection, infection and survival. A total of 109 patients was followed during the course of this study. There were 32 patients in Group 1, 49 patients in Group 2 and 28 patients in Group 3. Freedom from acute rejection at 1 and 3 years were higher in Group 3 compared with Group 1 (p < 0.05). The overall incidence of infection up to 3 years after transplantation was comparable among all three groups. Freedom from chronic rejection and survival at 1 and 3 years did not differ among the three groups. In conclusion, we determined the safety and efficacy of three potent immunosuppressive regimens in lung transplantation. Addition of daclizumab and MMF to a tacrolimus-based immunosuppressive regimen decreased the incidence of acute rejection episodes without increasing any adverse events in our lung transplantation population.

Original languageEnglish (US)
Pages (from-to)1570-1575
Number of pages6
JournalAmerican Journal of Transplantation
Volume3
Issue number12
DOIs
StatePublished - Dec 1 2003

Keywords

  • Acute rejection
  • Lung transplantation
  • Tacrolimus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Comparison of Three Tacrolimus-Based Immunosuppressive Regimens in Lung Transplantation'. Together they form a unique fingerprint.

  • Cite this

    Bhorade, S. M., Jordan, A., Villanueva, J., Yu, A., Kramer, H., Vigneswaran, W. T., & Garrity, E. R. (2003). Comparison of Three Tacrolimus-Based Immunosuppressive Regimens in Lung Transplantation. American Journal of Transplantation, 3(12), 1570-1575. https://doi.org/10.1046/j.1600-6135.2003.00260.x